Literature DB >> 12631553

Urinary excretion of viable podocytes in health and renal disease.

Stefanie U Vogelmann1, W James Nelson, Bryan D Myers, Kevin V Lemley.   

Abstract

The loss of glomerular visceral epithelial cells (podocytes) has been associated with the development of glomerular sclerosis and loss of renal function. Viability of podocytes recovered from urine of subjects with glomerular disease and of healthy controls was investigated by propidium iodide exclusion and TUNEL staining. Podocyte loss was quantified by cytospin. The growth behavior in culture of urinary cells and their expression of specific markers were examined. The majority of urinary podocytes are viable, although apoptosis occurs in about one-half of the cells. Patients with active glomerular disease excreted up to 388 podocytes/mg creatinine, whereas healthy controls and patients with quiescent disease generally excreted <0.5 podocytes/mg creatinine. The identity of cultured cells was confirmed by their morphology, growth behavior, and expression of podocyte-specific markers. The difference in growth behavior between healthy controls and subjects with active glomerular disease suggests that in active disease viable podocytes detach from the glomerular tuft due to local environmental factors rather than defects in the podocytes per se, whereas in healthy individuals mostly senescent podocytes are shed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631553      PMCID: PMC3368602          DOI: 10.1152/ajprenal.00404.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  24 in total

Review 1.  The role of the podocyte in glomerulosclerosis.

Authors:  W Kriz; K V Lemley
Journal:  Curr Opin Nephrol Hypertens       Date:  1999-07       Impact factor: 2.894

2.  Induction of differentiation in cultured rat and human podocytes.

Authors:  P Mundel; J Reiser; W Kriz
Journal:  J Am Soc Nephrol       Date:  1997-05       Impact factor: 10.121

Review 3.  Structure-stabilizing forces in the glomerular tuft.

Authors:  W Kriz; M Elger; P Mundel; K V Lemley
Journal:  J Am Soc Nephrol       Date:  1995-04       Impact factor: 10.121

Review 4.  Progression of glomerular diseases: is the podocyte the culprit?

Authors:  W Kriz; N Gretz; K V Lemley
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

5.  Evolution of incipient nephropathy in type 2 diabetes mellitus.

Authors:  K V Lemley; I Abdullah; B D Myers; T W Meyer; K Blouch; W E Smith; P H Bennett; R G Nelson
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions.

Authors:  P S Topham; S A Haydar; R Kuphal; J D Lightfoot; D J Salant
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

7.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

8.  Immunohistochemical and urinary markers of podocyte injury.

Authors:  M Hara; T Yanagihara; M Itoh; M Matsuno; I Kihara
Journal:  Pediatr Nephrol       Date:  1998-01       Impact factor: 3.714

9.  Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis.

Authors:  E Kemeny; M J Mihatsch; U Dürmüller; F Gudat
Journal:  Clin Nephrol       Date:  1995-02       Impact factor: 0.975

10.  Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis.

Authors:  M Hara; T Yamamoto; T Yanagihara; T Takada; M Itoh; Y Adachi; A Yoshizumi; K Kawasaki; I Kihara
Journal:  Nephron       Date:  1995       Impact factor: 2.847

View more
  114 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.

Authors:  Alison L Kent; Linda Brown; Margaret Broom; Amy Broomfield; Jane E Dahlstrom
Journal:  Pediatr Nephrol       Date:  2012-03-14       Impact factor: 3.714

3.  Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.

Authors:  Jin Zhang; Xiaozhou Hu; Shaoting Wang; Yan Zhang; Hong Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  A novel mouse model of podocyte depletion.

Authors:  L Wang; Y Tang; D N Howell; P Ruiz; R F Spurney
Journal:  Nephron Exp Nephrol       Date:  2012-10-19

Review 5.  Podocytes and glomerular function with aging.

Authors:  Jocelyn Wiggins
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

Review 6.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 7.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

Review 8.  Therapeutic targets in focal and segmental glomerulosclerosis.

Authors:  Peter J Lavin; Rasheed Gbadegesin; Tirupapuliyur V Damodaran; Michelle P Winn
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

9.  Conditionally immortalized human podocyte cell lines established from urine.

Authors:  Toru Sakairi; Yoshifusa Abe; Hiroshi Kajiyama; Linda D Bartlett; Lilian V Howard; Parmijit S Jat; Jeffrey B Kopp
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-02

Review 10.  Aging in the glomerulus.

Authors:  Jocelyn E Wiggins
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-07-25       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.